Literature DB >> 10069180

Transplantation strategies in type 1 primary hyperoxaluria: the issue of pyridoxine responsiveness.

M Marangella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10069180     DOI： 10.1093/ndt/14.2.301

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  8 in total

Review 1.  Current approaches to the management of primary hyperoxaluria.

Authors:  P Cochat; O Basmaison
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

2.  Primary hyperoxaluria type 1 with a novel mutation.

Authors:  Sidharth Kumar Sethi; Hans R Waterham; Sonika Sharma; Alok Sharma; Pankaj Hari; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2008-09-22       Impact factor: 1.967

3.  Liver transplantation in oxalosis prior to advanced chronic kidney disease.

Authors:  Jon I Scheinman
Journal:  Pediatr Nephrol       Date:  2010-07-29       Impact factor: 3.714

4.  Transplantation outcomes in primary hyperoxaluria.

Authors:  E J Bergstralh; C G Monico; J C Lieske; R M Herges; C B Langman; B Hoppe; D S Milliner
Journal:  Am J Transplant       Date:  2010-09-17       Impact factor: 8.086

5.  Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.

Authors:  A Santana; E Salido; A Torres; L J Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

Review 6.  Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review.

Authors:  Catherine M Clase; Vincent Ki; Rachel M Holden
Journal:  Semin Dial       Date:  2013-07-17       Impact factor: 3.455

Review 7.  Improving Treatment Options for Primary Hyperoxaluria.

Authors:  Bernd Hoppe; Cristina Martin-Higueras
Journal:  Drugs       Date:  2022-07-02       Impact factor: 11.431

8.  Extreme intrafamilial variability of Saudi brothers with primary hyperoxaluria type 1.

Authors:  Majid Alfadhel; Khalid A Alhasan; Mohammed Alotaibi; Khalid Al Fakeeh
Journal:  Ther Clin Risk Manag       Date:  2012-08-28       Impact factor: 2.423
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.